Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease

被引:305
作者
Giordano, Samantha [1 ,2 ]
Darley-Usmar, Victor [1 ,2 ]
Zhang, Jianhua [1 ,2 ,3 ]
机构
[1] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[3] Birmingham VA Med Ctr, Dept Vet Affairs, Birmingham, AL USA
关键词
Parkinson's disease; Protein aggregation; Neurons; Mitochondrial dysfunction; Reactive oxygen species; Anti-oxidants; Autophagy; Toxins; Clinical trials; Animal models; Redox signaling; INCREASED OXIDATIVE DAMAGE; HUMAN SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; LIPID-PEROXIDATION; NITRIC-OXIDE; DOPAMINERGIC-NEURONS; ENZYME-ACTIVITIES; DOUBLE-BLIND; RAT MODEL; MITOCHONDRIAL DYSFUNCTION;
D O I
10.1016/j.redox.2013.12.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Oxidative stress including DNA damage, increased lipid and protein oxidation, are important features of aging and neurodegeneration suggesting that endogenous antioxidant protective pathways are inadequate or overwhelmed. Importantly, oxidative protein damage contributes to age-dependent accumulation of dysfunctional mitochondria or protein aggregates. In addition, environmental toxins such as rotenone and paraquat, which are risk factors for the pathogenesis of neurodegenerative diseases, also promote protein oxidation. The obvious approach of supplementing the primary antioxidant systems designed to suppress the initiation of oxidative stress has been tested in animal models and positive results were obtained. However, these findings have not been effectively translated to treating human patients, and clinical trials for antioxidant therapies using radical scavenging molecules such as alpha-tocopherol, ascorbate and coenzyme Q have met with limited success, highlighting several limitations to this approach. These could include: (1) radical scavenging antioxidants cannot reverse established damage to proteins and organelles; (2) radical scavenging antioxidants are oxidant specific, and can only be effective if the specific mechanism for neurodegeneration involves the reactive species to which they are targeted and (3) since reactive species play an important role in physiological signaling, suppression of endogenous oxidants maybe deleterious. Therefore, alternative approaches that can circumvent these limitations are needed. While not previously considered an antioxidant system we propose that the autophagy-lysosomal activities, may serve this essential function in neurodegenerative diseases by removing damaged or dysfunctional proteins and organelles. (C) 2014 The Authors. Published by Elsevier B.V. All rights reserved
引用
收藏
页码:82 / 90
页数:9
相关论文
共 134 条
[1]
Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease [J].
Abramov, Andrey Yurevich ;
Gegg, Matthew ;
Grunewald, Anne ;
Wood, Nicholas William ;
Klein, Christine ;
Schapira, Anthony Henry Vernon .
PLOS ONE, 2011, 6 (10)
[2]
Alam ZI, 1997, J NEUROCHEM, V69, P1326
[3]
Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra [J].
Alam, ZI ;
Jenner, A ;
Daniel, SE ;
Lees, AJ ;
Cairns, N ;
Marsden, CD ;
Jenner, P ;
Halliwell, B .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) :1196-1203
[4]
DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase [J].
Andres-Mateos, Eva ;
Perier, Celine ;
Zhang, Li ;
Blanchard-Fillion, Beatrice ;
Greco, Todd M. ;
Thomas, Bobby ;
Ko, Han Seok ;
Sasaki, Masayuki ;
Ischiropoulos, Harry ;
Przedborski, Serge ;
Dawson, Ted M. ;
Dawson, Valina L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (37) :14807-14812
[5]
THE DETERMINATION OF HYDROXYDOPAMINES AND OTHER TRACE AMINES IN THE URINE OF PARKINSONIAN-PATIENTS AND NORMAL CONTROLS [J].
ANDREW, R ;
WATSON, DG ;
BEST, SA ;
MIDGLEY, JM ;
WENLONG, H ;
PETTY, RKH .
NEUROCHEMICAL RESEARCH, 1993, 18 (11) :1175-1177
[6]
[Anonymous], BIOCH BIOPHYS ACTA
[7]
A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease [J].
Bahat-Stroomza, M ;
Gilgun-Sherki, Y ;
Offen, D ;
Panet, H ;
Saada, A ;
Krool-Galron, N ;
Barzilai, A ;
Atlas, D ;
Melamed, E .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (03) :637-646
[8]
Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain [J].
Bashkatova, V ;
Alam, M ;
Vanin, A ;
Schmidt, WJ .
EXPERIMENTAL NEUROLOGY, 2004, 186 (02) :235-241
[9]
Understanding peroxynitrite biochemistry and its potential for treating human diseases [J].
Beckman, Joseph S. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2009, 484 (02) :114-116
[10]
Creatine supplementation in Parkinson disease:: A placebo-controlled randomized pilot trial [J].
Bender, A. ;
Koch, W. ;
Elstner, M. ;
Schombacher, Y. ;
Bender, J. ;
Moeschl, M. ;
Gekeler, F. ;
Mueller-Myhsok, B. ;
Gasser, T. ;
Tatsch, K. ;
Klopstock, T. .
NEUROLOGY, 2006, 67 (07) :1262-1264